Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 3Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Suspected Central Nervous System Tumors 1Stomach Neoplasms 1Solitary Pulmonary Nodule 1Rectal Neoplasms 1Multiple Pulmonary Nodules 1Lymphedema 1Head and Neck Neoplasms 1Head and Neck Carcinoma 1Giant Cell Tumor of Bone 1Colorectal Neoplasms 1Chylothorax 1Breast Neoplasms 1

Interventions

Cetuximab 44Oxaliplatin 39Irinotecan 38Fluorouracil 36Capecitabine 36pembrolizumab 35Leucovorin 35Bevacizumab 35Nivolumab 21Gemcitabine 17regorafenib 13Panitumumab 12IFL protocol 12Folfox protocol 12Cyclophosphamide 12Pemetrexed 11Cisplatin 11tislelizumab 9Paclitaxel 9HMPL-013 9Carboplatin 9130-nm albumin-bound paclitaxel 8durvalumab 7Specimen Handling 7Docetaxel 7trametinib 6Trifluridine 6Ipilimumab 6Drug Therapy 6trifluridine tipiracil drug combination 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Colorectal Neoplasms × Indocyanine Green × Clear all
NCT05092750 2023-09-28

Magnetic Particle-ICG Lymph Node Mapping in Colorectal Cancer

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡